Medplus Health Services (NSE:MEDPLUS) Moat Score: 0/10 (As of Jul. 11, 2026)


NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
83 GF Score
Price ₹826.10
GF Value ₹958.14
Valuation Modestly Undervalued
View Full Analysis

What is Medplus Health Services Moat Score?

Medplus Health Services has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Medplus Health Services has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Medplus Health Services might have No Moat - No discernible moat.

Medplus Health Services  (NSE:MEDPLUS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Medplus Health Services Moat Score Related Terms

NSE:MEDPLUS
83GF Score
Medplus Health Services Ltd NSE:MEDPLUS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹826.10 is trading 13.8% below its estimated GF Value™ of ₹958.14. GuruFocus considers Medplus Health Services to be Modestly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • Moat Score: 0
  • GF Value™: ₹958.14 vs. price of ₹826.10 (13.8% below fair value)
  • GF Score™: 83/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
83GF Score

Get the complete analysis for NSE:MEDPLUS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹826.10
Price
₹958.14
GF Value